| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.4 |